Treatment-resistant ulcerative necrobiosis lipoidica in a diabetic patient responsive to ustekinumab.
Dermatol Online J
; 25(8)2019 Aug 15.
Article
em En
| MEDLINE
| ID: mdl-31553866
ABSTRACT
Necrobiosis lipoidica is a chronic granulomatous disease of unknown etiopathogenesis, which is often difficult to treat. While data from randomized controlled trials for the treatment of necrobiosis lipoidica is lacking, several treatments of varying efficacy for necrobiosis lipoidica have been reported in the scientific literature. We present a case of a 29-year-old female with uncontrolled diabetes and treatment-resistant necrobiosis lipoidica which was responsive to ustekinumab.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Fármacos Dermatológicos
/
Ustekinumab
/
Necrobiose Lipoídica
Tipo de estudo:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article